Core Viewpoint - Citigroup's report indicates that Hengan International's net profit is expected to rebound by 31% year-on-year in the second half of 2025, driven by a recovery in gross margin from a low base, aligning with the bank's expectations [1] Financial Performance - Revenue is projected to grow by 4%, meeting forecasts, with improvements in tissue and hygiene product sales offsetting declines in other business segments [1] - Gross margins across all business segments exceeded expectations, although lower government subsidies and higher advertising and promotional expenses offset this, resulting in operating profit and net profit meeting projections [1] Management Outlook - Despite the stable performance in the second half of 2025, management aims to maintain stable sales and profit margins in 2026 due to intense competition and potential pressure from raw material costs [1] - Management plans to address potential challenges by improving product mix and enhancing operational efficiency [1] Forecast Adjustments - Citigroup has slightly adjusted its net profit forecasts for Hengan for 2026 and 2027 by approximately 1% [1] - The target price based on the sum-of-the-parts valuation method has been raised from HKD 27 to HKD 28.2, while maintaining a "Neutral" rating [1]
大行评级丨花旗：恒安国际去年下半年业绩稳健，目标价上调28.2港元